These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman disease. Simko SJ; Tran HD; Jones J; Bilgi M; Beaupin LK; Coulter D; Garrington T; McCavit TL; Moore C; Rivera-Ortegón F; Shaffer L; Stork L; Turcotte L; Welsh EC; Hicks MJ; McClain KL; Allen CE Pediatr Blood Cancer; 2014 Mar; 61(3):479-87. PubMed ID: 24106153 [TBL] [Abstract][Full Text] [Related]
4. Clofarabine monotherapy in aggressive, relapsed and refractory Langerhans cell histiocytosis. Parekh D; Lin H; Batajoo A; Peckham-Gregory E; Karri V; Stanton W; Scull B; Fleishmann R; El-Mallawany N; Eckstein OS; Prudowsky ZD; Gulati N; Agrusa JE; Ahmed AZ; Chu R; Dietz MS; Goldman SC; Hogarty MD; Imran H; Intzes S; Kim JM; Kopp LM; Levy CF; Neff P; Pillai PM; Sisk BA; Schiff DE; Trobaugh-Lotrario AD; Walkovich K; McClain KL; Allen CE Br J Haematol; 2024 May; 204(5):1888-1893. PubMed ID: 38501389 [TBL] [Abstract][Full Text] [Related]
5. Clofarabine for the treatment of acute lymphoblastic leukemia. Jeha S; Kantarjian H Expert Rev Anticancer Ther; 2007 Feb; 7(2):113-8. PubMed ID: 17288522 [TBL] [Abstract][Full Text] [Related]
6. Clofarabine for the treatment of adult acute myeloid leukemia. Thomas X; Raffoux E; Elhamri M; Lobe I; Cannas G; Dombret H Future Oncol; 2009 Oct; 5(8):1197-210. PubMed ID: 19852733 [TBL] [Abstract][Full Text] [Related]
7. Clofarabine: a new treatment option for patients with acute myeloid leukemia. Larson ML; Venugopal P Expert Opin Pharmacother; 2009 Jun; 10(8):1353-7. PubMed ID: 19463072 [TBL] [Abstract][Full Text] [Related]
8. Clofarabine in pediatric acute leukemia: current findings and issues. Hijiya N; Barry E; Arceci RJ Pediatr Blood Cancer; 2012 Sep; 59(3):417-22. PubMed ID: 22354543 [TBL] [Abstract][Full Text] [Related]
9. Comparison of clofarabine activity in childhood and adult acute leukemia: individual tumor response study. Styczynski J; Gil L; Derwich K; Wachowiak J; Balwierz W; Badowska W; Krawczuk-Rybak M; Matysiak M; Wieczorek M; Balcerska A; Sonta-Jakimczyk D; Stefaniak J; Kowalczyk J; Urasinski T; Sobol G; Komarnicki M; Wysocki M Anticancer Res; 2009 May; 29(5):1643-50. PubMed ID: 19443380 [TBL] [Abstract][Full Text] [Related]
10. Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia. Jeha S; Gaynon PS; Razzouk BI; Franklin J; Kadota R; Shen V; Luchtman-Jones L; Rytting M; Bomgaars LR; Rheingold S; Ritchey K; Albano E; Arceci RJ; Goldman S; Griffin T; Altman A; Gordon B; Steinherz L; Weitman S; Steinherz P J Clin Oncol; 2006 Apr; 24(12):1917-23. PubMed ID: 16622268 [TBL] [Abstract][Full Text] [Related]
11. Multiply relapsed mixed histiocytosis in an adult responding to clofarabine after failure of cladribine. Othman J; Bonar F; Brown W; Boyle R; Khoo TL Leuk Lymphoma; 2020 Feb; 61(2):477-480. PubMed ID: 31483174 [No Abstract] [Full Text] [Related]
12. Clofarabine and nelarabine: two new purine nucleoside analogs. Gandhi V; Plunkett W Curr Opin Oncol; 2006 Nov; 18(6):584-90. PubMed ID: 16988579 [TBL] [Abstract][Full Text] [Related]
13. Clofarabine (2-chloro-2'-fluoro-2'-deoxyarabinosyladenine)--biochemical aspects of anticancer activity. Majda K; Lubecka K; Kaufman-Szymczyk A; Fabianowska-Majewska K Acta Pol Pharm; 2011; 68(4):459-66. PubMed ID: 21796927 [TBL] [Abstract][Full Text] [Related]
14. Early UK experience in the use of clofarabine in the treatment of relapsed and refractory paediatric acute lymphoblastic leukaemia. O'Connor D; Sibson K; Caswell M; Connor P; Cummins M; Mitchell C; Motwani J; Taj M; Vora A; Wynn R; Kearns PR Br J Haematol; 2011 Aug; 154(4):482-5. PubMed ID: 21689087 [TBL] [Abstract][Full Text] [Related]
15. Recent progress in the treatment of acute lymphoblastic leukemia: clofarabine. Jeha S Hematol Oncol Clin North Am; 2009 Oct; 23(5):1137-44, viii. PubMed ID: 19825457 [TBL] [Abstract][Full Text] [Related]
16. Clofarabine in the treatment of newly diagnosed acute myeloid leukemia in older adults. Tran H; Yang D Ann Pharmacother; 2012 Jan; 46(1):89-96. PubMed ID: 22170975 [TBL] [Abstract][Full Text] [Related]
17. Clofarabine induced durable complete remission in heavily pretreated adolescents with relapsed and refractory leukemia. Steinherz PG; Meyers PA; Steinherz LJ; Jeha S J Pediatr Hematol Oncol; 2007 Sep; 29(9):656-8. PubMed ID: 17805046 [TBL] [Abstract][Full Text] [Related]
18. Phase II study of clofarabine in pediatric patients with refractory or relapsed acute myeloid leukemia. Jeha S; Razzouk B; Rytting M; Rheingold S; Albano E; Kadota R; Luchtman-Jones L; Bomgaars L; Gaynon P; Goldman S; Ritchey K; Arceci R; Altman A; Stine K; Steinherz L; Steinherz P J Clin Oncol; 2009 Sep; 27(26):4392-7. PubMed ID: 19652076 [TBL] [Abstract][Full Text] [Related]
19. Clofarabine as a novel nucleoside analogue approved to treat patients with haematological malignancies: mechanism of action and clinical activity. Lech-Maranda E; Korycka A; Robak T Mini Rev Med Chem; 2009 Jun; 9(7):805-12. PubMed ID: 19519505 [TBL] [Abstract][Full Text] [Related]
20. [Therapeutic effect of clofarabine in children with relapsed or refractory acute lymphoblastic leukemia]. Suo P; Zhang LP; Wu J; Lu AD; Wang B; Zuo YX; Cheng YF; Liu GL Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jun; 15(6):444-7. PubMed ID: 23791059 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]